Taiwan
· Delayed Price · Currency is TWD BRIM Biotechnology Statistics
Total Valuation
BRIM Biotechnology has a market cap or net worth of TWD 5.63 billion. The enterprise value is 4.07 billion.
| Market Cap | 5.63B |
| Enterprise Value | 4.07B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BRIM Biotechnology has 115.75 million shares outstanding. The number of shares has increased by 34.21% in one year.
| Shares Outstanding | 115.75M |
| Shares Change (YoY) | +34.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.19% |
| Owned by Institutions (%) | 0.10% |
| Float | 111.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 60,372.67 |
| PB Ratio | 3.48 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.77 |
Financial Position
The company has a current ratio of 63.15, with a Debt / Equity ratio of 0.09.
| Current Ratio | 63.15 |
| Quick Ratio | 62.69 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -6,792.93 |
Financial Efficiency
Return on equity (ROE) is -55.57% and return on invested capital (ROIC) is -36.36%.
| Return on Equity (ROE) | -55.57% |
| Return on Assets (ROA) | -35.77% |
| Return on Capital (ROIC) | -36.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.05% in the last 52 weeks. The beta is 1.29, so BRIM Biotechnology's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -37.05% |
| 50-Day Moving Average | 45.57 |
| 200-Day Moving Average | 41.02 |
| Relative Strength Index (RSI) | 64.94 |
| Average Volume (20 Days) | 499,612 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRIM Biotechnology had revenue of TWD 90,000 and -659.76 million in losses. Loss per share was -5.90.
| Revenue | 90,000 |
| Gross Profit | 90,000 |
| Operating Income | -692.88M |
| Pretax Income | -659.76M |
| Net Income | -659.76M |
| EBITDA | -690.96M |
| EBIT | -692.88M |
| Loss Per Share | -5.90 |
Balance Sheet
The company has 1.56 billion in cash and 1.53 million in debt, giving a net cash position of 1.56 billion or 13.47 per share.
| Cash & Cash Equivalents | 1.56B |
| Total Debt | 1.53M |
| Net Cash | 1.56B |
| Net Cash Per Share | 13.47 |
| Equity (Book Value) | 1.62B |
| Book Value Per Share | 13.95 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was -598.96 million and capital expenditures -2.09 million, giving a free cash flow of -601.05 million.
| Operating Cash Flow | -598.96M |
| Capital Expenditures | -2.09M |
| Free Cash Flow | -601.05M |
| FCF Per Share | -5.19 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -769,865.56% |
| Pretax Margin | -733,063.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -667,836.67% |
Dividends & Yields
BRIM Biotechnology does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.21% |
| Shareholder Yield | -34.21% |
| Earnings Yield | -12.14% |
| FCF Yield | -10.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |